Genostis AG logo — Swiss Generic Osteosynthesis

Genostis AG

Swiss Generic Osteosynthesis

Founded 2005 Switzerland Burgdorf, Switzerland 21 employees Health Care

General Information

Company Name Genostis AG
Founded Year 2005
Location Switzerland Burgdorf, Switzerland
Employees 21
Industries Health Care
Social

BounceWatch is an independent company data service, not affiliated with Genostis AG. To contact Genostis AG, visit genostis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Genostis AG

Genostis AG is a Swiss company specializing in generic titanium bone implant systems. MDR-certified and following the AO Principles of Fracture Management, their implants cover up to 90% of fractures. The company's Swiss-made implants are of premium quality and boast significantly more cost-effectiveness compared to others in the market. With expertise and automated, digitalized production processes, Genostis is setting new standards in bone implants. The company's vision of global implant supply led to the launch of the brand in 2022, although the team behind it possesses decades of experience and expertise in the international medical technology industry. Genostis is driving a shift in the healthcare system by enabling hospitals to reduce purchasing costs and simplify processes while providing surgeons with internationally renowned, safe, and quality implants that have proven themselves over decades. Founded in 2005, the company operates in the Health Care industry with its headquarters in Switzerland. As of now, there is no public record of the last investment or the involved investors in Genostis AG. With its innovative approach to bone implant systems and the potential to revolutionize healthcare processes and costs, Genostis AG stands as an intriguing prospect for investors in the medical technology sector.

Taxonomy: Swiss manufacturer, titanium bone implant, MDR-certified, AO Principles of Fracture Management, premium-quality implants, automated production processes, medical technology industry, generic implants, osteosynthesis, orthopedics, trauma treatment, fracture management, healthcare systems, cost-effective implants, Swiss-made implants

No funding data available for Genostis AG yet.

Genostis AG Alternatives & Competitors

Genostis AG vs

Innovation to move...

69 employees
Health Care, Manufacturing
Genostis AG vs

Disrupting & innovating sterile implant delivery by leveraging proprietary RFID-enabled technology.

Series A
10 employees
Biotechnology, Digital Health
Genostis AG vs

Pioneers in the treatment of drug-resistant fluid overload in liver disease, heart failure and cance...

Post-IPO Equity
37 employees
Biotechnology, Health Care

FAQ About Genostis AG

Swiss Generic Osteosynthesis
Genostis AG was founded in 2005.
Genostis AG is headquartered in Burgdorf, Switzerland.
Genostis AG operates in Health Care. Its work centres on Swiss manufacturer, titanium bone implant, MDR-certified and AO Principles of Fracture Management.
Genostis AG has approximately 21 employees.
Top alternatives and competitors to Genostis AG include Zimed Medical, Gramercy Extremity Orthopedics, Sequana Medical NV, IPR Medical, Shenzhen Dartmon Biotechnology Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genostis AG and Zimed Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genostis AG, https://bouncewatch.com/company/genostis-ag, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes